頭頸癌診斷全球市場報告：趨勢、預測與競爭分析（至2031年）

全球頭頸癌診斷市場前景光明，醫院、門診手術中心和診斷中心市場都存在機會。預計到2031年全球頭頸癌診斷市場規模將達到 34億美元，2025-2031年期間的年複合成長率為 7.1%。這個市場的主要驅動力是頭頸癌盛行率的不斷上升、醫療保健服務的改善以及人們對頭頸癌的體徵和症狀以及早期發現的重要性的認知不斷提高。

• Lucintel 預測，基於診斷，影像將在預測期內經歷最高的成長。
• 根據最終用途，醫院可能繼續成為最大的細分市場，因為它們具有更好的疾病診斷能力，並配備了最新的醫療設備和技術，可以為患者提供最佳的治療。
• 從地區來看，北美預計將在預測期內繼續保持最大地區地位，因為該地區擁有強大的醫療保健基礎設施、優惠的償付政策、對疾病的高度認知以及政府對醫療保健行業發展的支持。

頭頸癌診斷市場的策略性成長機會

頭頸癌診斷市場在多種應用領域提供了多種成長機會。了解這些機會將有助於相關人員選擇投資和發展的領域。

• 分子診斷：對分子診斷測試日益成長的需求為市場創造了巨大的機會。這些測試可以早期發現和分類頭頸癌，提供有效治療所需的重要資訊。
• 人工智慧增強成像解決方案：醫療保健專業人員需要人工智慧增強成像解決方案來提高診斷準確性。這些技術具有巨大的潛力，可以開發和推廣，以提高診斷效率和患者管理。
• 液態切片應用：液態切片液態生物檢體的日益廣泛使用將推動收益成長。用於早期診斷和治療評估的非侵入性測試迅速湧現，使患者和醫療服務提供者都受益。
• 與遠端醫療的整合：遠端醫療整合透過遠距提供診斷服務提供了真正的成長機會。擴大遠距離診斷工具市場可以改善患者照護，尤其是在偏遠地區。
• 致力於合作研究：學術和臨床研究機構之間的合作促進了可銷售的診斷工具和技術的快速發展。這些舉措將有助於企業在市場上更具競爭力。

這些策略性成長機會解決了頭頸癌診斷市場中新出現的空白，使相關人員能夠培養創新解決方案，增強病患管理和市場競爭力。

頭頸癌診斷市場促進因素與挑戰

推動市場發展的因素包括診斷技術的進步、公眾對癌症篩檢和治療的認知不斷提高以及醫療保健預算的增加。挑戰包括監管障礙、昂貴的診斷方法以及某些地區某些技術的短缺。

頭頸癌診斷市場受以下因素驅動：

• 技術進步：診斷服務市場隨著成熟和新興的分子測試的不斷進步而不斷發展。這些發展提高了頭頸癌診斷的效率和及時性，增加了對診斷程序的需求。
• 擴大癌症教育的覆蓋範圍：公共衛生宣傳活動提高人們對癌症（包括頭頸癌）早期發現的認知。這使得更多的人接受篩檢和診斷。
• 醫療保健支出增加：新興市場的醫療保健支出日益增加，可以投資於診斷工具。這些市場的醫療機構引進新的診斷設備，改善優質醫療服務，推動市場成長。
• 老年人口不斷增加：人口老化導致頭頸癌發生率不斷上升。老年人口的成長推動了對診斷服務的需求，進一步推動了市場成長。
• 標靶治療方案：隨著更多標靶治療的開發，對與這些療法相符的先進診斷工具的需求也日益增加。根據患者獨特的健康狀況來診斷癌症增加了對客製化診斷工具的需求。

頭頸癌診斷市場面臨的挑戰如下：

• 昂貴的先進診斷工具：新的診斷設備通常價格昂貴，限制了其在資源貧乏地區的使用。這可能會導致診斷、治療和復原的延遲。
• 監理合規挑戰：對於公司來說，遵守診斷市場的複雜法規可能是一項艱鉅的任務。遵守各種標準和法律的成本可能很高，並且會減緩新產品進入市場的速度。
• 獲得先進診斷技術的機會有限：許多地區，特別是發展中國家，獲得先進診斷技術的機會有限。這會導致早期檢測率降低和護理品質差，需要採取適當的解決方案。

頭頸癌診斷市場受到促進因素和挑戰的影響。了解這些因素對於相關人員提供滿足市場需求並利用成長機會的解決方案非常重要。

目錄

第1章 執行摘要

第2章 全球頭頸癌診斷市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球頭頸癌診斷市場趨勢（2019-2024）及預測（2025-2031）
• 全球頭頸癌診斷市場（依類型）
  • 喉癌
  • 咽癌
  • 唾液腺癌
  • 唇癌和口腔癌
  • 鼻咽癌
  • 其他
• 全球頭頸癌診斷市場（依診斷）
  • 切片篩檢測試
  • 血液檢查
  • 牙科診斷
  • 影像學診斷
  • 內視鏡檢查
• 全球頭頸癌診斷市場（依療法）
  • 化療
  • 放射治療
  • 標靶治療
  • 外科手術
  • 其他
• 全球頭頸癌診斷市場（依最終用途）
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 其他

第4章 各地區市場趨勢及預測分析（2019-2031）

• 全球頭頸癌診斷市場（依地區）
• 北美頭頸癌診斷市場
• 歐洲頭頸癌診斷市場
• 亞太地區頭頸癌診斷市場
• 世界其他地區頭頸癌診斷市場

第5章 競爭分析

• 產品系列分析
• 運作整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球頭頸癌診斷市場成長機會（依類型）
  • 全球頭頸癌診斷市場成長機會（依診斷）
  • 全球頭頸癌診斷市場成長機會（依療法）
  • 全球頭頸癌診斷市場成長機會（依最終用途）
  • 全球頭頸癌診斷市場成長機會（依地區）
• 全球頭頸癌診斷市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球頭頸癌診斷市場的產能擴張
  • 全球頭頸癌診斷市場的合併、收購與合資企業
  • 認證和許可

第7章 主要企業簡介

• GE Healthcare
• Philips
• Siemens Healthineers
• Merck
• Eli Lilly

The future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2031 with a CAGR of 7.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of head and neck cancer, surfing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

• Lucintel forecasts that, within the diagnosis category, imaging is expected to witness the highest growth over the forecast period.
• Within the end use category, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also has the latest medical equipment and technology, which allows them to provide patients with the best possible care.
• In terms of regions, North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is changing rapidly, and there are trends that will determine its future. These trends involve new ways of diagnosing and managing patients, as well as new treatment options.

• Liquid Biopsy Development: Head and neck cancers may be diagnosed at an earlier stage when biopsies are not compatible with surgery. Liquid biopsies are becoming an accepted method of non-invasive tumor identification. They evaluate tumor cells in the bloodstream, providing both diagnosis and responses to treatment sooner than otherwise possible. This phenomenon is changing modern oncology by providing real-time information about tumor growth and response to therapy.
• Artificial Intelligence in Diagnostics: There is a growing trend towards enhancing head and neck cancer diagnostics through artificial intelligence and machine learning. AI algorithms can assist individuals without prior training to review CT or MR imaging studies and analyze clinical data, thus enhancing clinical decision-making. This technology improves accuracy and efficiency in analyzing images, which are often time-consuming.
• Personalization of Medicine Gaining Momentum: The increasing use of personalized medicine is driving a new trend toward personalized diagnostics and treatment methods. Genetic and molecular profiling helps determine distinct biomarkers for head and neck cancers, enabling targeted treatment that is more effective and less harmful.
• Telemedicine and Remote Diagnostic Interfaces: The use of telemedicine for diagnosing head and neck cancers is increasing, particularly in rural and underserved areas. Patients can be treated remotely by monitoring their symptoms and providing timely interventions, which alleviates the burden on healthcare facilities. This expansion helps with early diagnosis of cancers.
• Growing Cooperation between Academia and Industry: The collaboration between research centers and companies is becoming more active, with the goal of improving head and neck cancer diagnosis. These partnerships aim to foster the invention of better diagnostic tools, benefiting both the healthcare sector and the business environment.

Such trends are likely to positively affect the head and neck cancer diagnostic market by spurring new solutions, increasing diagnostic accuracy, and enabling individualized treatment. Shortly, the integration of new technologies and collaborations is expected to improve clinical outcomes and transform cancer care.

Recent Developments in the Head and Neck Cancer Diagnostic Market

The market for head and neck cancer diagnosis has undergone significant changes, leading to improved detection, accuracy, and patient management. Notable changes include technological advancements, regulatory approvals, and research collaborations.

• Regulatory Approvals for Biomarkers: The recent FDA approvals of new biomarkers for head and neck cancers are promoting the diagnosis of these cancers. These tests are useful not only for tumor identification but also for assessing specific tumor features, aiding in the early administration of appropriate treatments, and improving clinical outcomes.
• Imaging Technologies Upgrading: Advanced imaging technologies, such as 3D imaging and hybrid PET/CT scans, are now part of routine diagnostic practice, enabling precise diagnosis of head and neck cancers. These technologies improve treatment planning and monitoring for patients with head and neck tumors.
• Designing Liquid Biopsies: Liquid biopsy test kits have revolutionized the prospects of diagnosing head and neck tumors. They allow for earlier cancer detection and enable treatment response assessments through simple blood tests instead of invasive procedures.
• The Role of AI in Cancer Diagnosis: The application of artificial intelligence in imaging interpretation is increasing. AI algorithms can process vast amounts of imaging data with high accuracy, spotting tumors and minimizing human error, thus enhancing diagnostic effectiveness.
• Telehealth Services: Telehealth services are improving access to diagnostic consultations, especially in rural areas. This approach provides efficient care, reducing the need for patients to visit healthcare facilities.

These trends are transforming the head and neck cancer diagnostic market by enhancing diagnostic accuracy, expanding access to cancer treatment, and enabling customized therapies. Over time, technological advancements are expected to further improve patient outcomes.

Strategic Growth Opportunities for Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market offers various growth opportunities across multiple applications. Understanding these opportunities helps stakeholders choose areas for investment and development.

• Molecular Diagnostics: The growing demand for molecular diagnostic tests offers a significant opportunity in the market. These tests enable early detection and classification of head and neck cancers, providing critical information needed for effective treatment.
• AI-Enhanced Imaging Solutions: Healthcare professionals require AI-enhanced imaging solutions that improve diagnostic accuracy. These technologies have high potential and can be developed and marketed to enhance diagnostic efficiency and patient management.
• Liquid Biopsy Applications: Expanding the use of liquid biopsy applications can drive revenue growth. Non-invasive tests for early-stage diagnosis and treatment evaluation are rapidly emerging, benefiting both patients and service providers.
• Telehealth Integration: The integration of telehealth offers an authentic growth opportunity by providing diagnostic services remotely. Expanding the market for remote diagnostic tools can improve patient care, especially in distant locations.
• Initiatives for Collaborative Research: Collaboration between academic and clinical research institutions can lead to faster development of marketable diagnostic tools and techniques. These initiatives can help companies become more competitive in the market.

These strategic growth opportunities address emerging gaps in the head and neck cancer diagnostic market, allowing stakeholders to foster innovative solutions that enhance patient management and competitiveness.

Head and Neck Cancer Diagnostic Market Driver and Challenges

The major drivers in the market include advancements in diagnostic technology, increasing public awareness of cancer screening and treatment, and higher healthcare budgets. Challenges include regulatory hurdles, expensive diagnostic methods, and the lack of certain technologies in some regions.

The factors driving the head and neck cancer diagnostic market include:

• Technological Advancements: The diagnostic services market is evolving with continuous advancements in both established and emerging molecular-based tests. These developments improve the efficiency and timing of head and neck cancer diagnoses, leading to increased demand for diagnostic procedures.
• Expanding the Scope of Cancer Education: Public health campaigns have increased awareness about the early detection of cancers, including head and neck cancer. This is encouraging more people to undergo screenings and diagnostics.
• Increasing Healthcare Spending: Emerging markets are increasing healthcare spending, enabling investments in diagnostic tools. Healthcare institutions in these markets are acquiring new diagnostic equipment, improving access to quality healthcare, and facilitating market growth.
• Geriatric Population: The aging population is contributing to a rise in head and neck cancer prevalence. As the elderly population grows, the demand for diagnostic services increases, further driving market growth.
• Targeted Therapy Programs: As more targeted therapies are developed, the demand for advanced diagnostic tools that match these therapies is increasing. Diagnosing cancers based on each patient's specific health condition will drive the need for tailored diagnostic tools.

Challenges in the head and neck cancer diagnostic market include:

• Advanced Diagnostic Tools are Costly: New diagnostic devices are often expensive, limiting their use in resource-poor areas. This can result in delays in diagnosis and treatment, leading to poorer recovery outcomes.
• Challenges Associated with Regulatory Compliance: Navigating complex regulations in the diagnostic market can be daunting for companies. Compliance with various standards and laws can be costly and delay the market entry of new products.
• Limited Reach to Advanced Diagnostic Technologies: Access to advanced diagnostic technology is limited in many areas, particularly in developing countries. This can result in lower early detection rates and reduced care quality, which needs to be addressed through relevant solutions.

The head and neck cancer diagnostic market is shaped by both enablers and obstacles. Understanding these factors is crucial for stakeholders to offer solutions that meet market needs while taking advantage of growth opportunities.

List of Head and Neck Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies head and neck cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the head and neck cancer diagnostic companies profiled in this report include-

• GE Healthcare
• Philips
• Siemens Healthineers
• Merck
• Eli Lilly

Head and Neck Cancer Diagnostic by Segment

The study includes a forecast for the global head and neck cancer diagnostic market by type, diagnosis, treatment, end use, and region.

Head and Neck Cancer Diagnostic Market by Type [Analysis by Value from 2019 to 2031]:

• Laryngeal Cancer
• Pharyngeal Cancer
• Salivary Gland Cancer
• Lip & Oral Cavity Cancer
• Nasopharyngeal Cancer
• Others

Head and Neck Cancer Diagnostic Market by Diagnosis [Analysis by Value from 2019 to 2031]:

• Bioscopy Screening Tests
• Blood Tests
• Dental Diagnosis
• Imaging
• Endoscopy

Head and Neck Cancer Diagnostic Market by Treatment [Analysis by Value from 2019 to 2031]:

• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Surgery
• Others

Head and Neck Cancer Diagnostic Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Others

Head and Neck Cancer Diagnostic Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is making significant progress due to technological advancements, rising demand for cancer diagnosis, and increased awareness about early detection. The United States, China, Germany, India, and Japan are investing in R&D to advance diagnostic techniques for head and neck cancer. These developments aim to improve healthcare quality by enhancing diagnostic accuracy, reducing costs, and enabling timely action.

• United States: Advances in molecular diagnosis and liquid biopsy strategies are revolutionizing the diagnosis of head and neck cancer. The development of targeted therapies and improvements in diagnostic imaging technologies, such as artificial intelligence, are also enhancing diagnostic accuracy and efficiency.
• China: China's growing healthcare investment is driving innovations in cancer diagnosis, particularly for head and neck cancers. New imaging devices, such as advanced CT scanners, are being adopted, and there is a strong focus on the development of genetic testing kits for screening cancer susceptibility.
• Germany: Germany is making significant strides in creating accurate diagnostic tools for head and neck cancers. New research emphasizes the use of directed imaging radionics to increase sensitivity to early tumor changes, while collaborative efforts between universities and healthcare companies are developing innovative biopsy techniques.
• India: Efforts in India are focused on improving the accessibility of head and neck cancer diagnostic services, especially in rural areas. Initiatives such as telemedicine and mobile health services aim to improve access, while cost-effective diagnostic studies are being conducted to create affordable screening tests.
• Japan: Japan is at the forefront of head and neck cancer management, with advanced imaging systems incorporated into diagnostic practices. Combined imaging modalities like PET-CT are improving diagnostic efficacy, while targeted therapy development based on cancer genomics is enhancing personalized medicine in the country.

Features of the Global Head and Neck Cancer Diagnostic Market

Market Size Estimates: Head and neck cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Head and neck cancer diagnostic market size by various segments, such as by type, diagnosis, treatment, end use, and region in terms of ($B).

Regional Analysis: Head and neck cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end uses, and regions for the head and neck cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the head and neck cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the head and neck cancer diagnostic market by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Head and Neck Cancer Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Head and Neck Cancer Diagnostic Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Head and Neck Cancer Diagnostic Market by Type
  • 3.3.1: Laryngeal Cancer
  • 3.3.2: Pharyngeal Cancer
  • 3.3.3: Salivary Gland Cancer
  • 3.3.4: Lip & Oral Cavity Cancer
  • 3.3.5: Nasopharyngeal Cancer
  • 3.3.6: Others
• 3.4: Global Head and Neck Cancer Diagnostic Market by Diagnosis
  • 3.4.1: Bioscopy Screening Tests
  • 3.4.2: Blood Tests
  • 3.4.3: Dental Diagnosis
  • 3.4.4: Imaging
  • 3.4.5: Endoscopy
• 3.5: Global Head and Neck Cancer Diagnostic Market by Treatment
  • 3.5.1: Chemotherapy
  • 3.5.2: Radiation Therapy
  • 3.5.3: Targeted Therapy
  • 3.5.4: Surgery
  • 3.5.5: Others
• 3.6: Global Head and Neck Cancer Diagnostic Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Ambulatory Surgical Centers
  • 3.6.3: Diagnostic Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Head and Neck Cancer Diagnostic Market by Region
• 4.2: North American Head and Neck Cancer Diagnostic Market
  • 4.2.1: North American Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
• 4.3: European Head and Neck Cancer Diagnostic Market
  • 4.3.1: European Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
• 4.4: APAC Head and Neck Cancer Diagnostic Market
  • 4.4.1: APAC Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
• 4.5: ROW Head and Neck Cancer Diagnostic Market
  • 4.5.1: ROW Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
  • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Diagnosis
  • 6.1.3: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Treatment
  • 6.1.4: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by End Use
  • 6.1.5: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Head and Neck Cancer Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Head and Neck Cancer Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Head and Neck Cancer Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GE Healthcare
• 7.2: Philips
• 7.3: Siemens Healthineers
• 7.4: Merck
• 7.5: Eli Lilly